GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing
Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.
Read More
Search Results for: lung cancer
NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026
Presentations at the upcoming annual meeting will focus on AI-based analysis, biomarker prevalence, and therapy development.
Read More
Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
Read More
GRAIL and Epic Partner to Integrate Multi-Cancer Early Detection Test into EHR
The collaboration allows clinicians to order the Galleri test and view results directly within existing electronic health record workflows.
Read More
Trinity Biotech and University at Buffalo Partner to Commercialize Sjögren’s Syndrome Biomarkers
The collaboration focuses on advancing proprietary biomarkers for the earlier and more accurate detection of the autoimmune disease.
Read More